Chemistry: natural resins or derivatives; peptides or proteins; – Proteins – i.e. – more than 100 amino acid residues – Blood proteins or globulins – e.g. – proteoglycans – platelet...
Reexamination Certificate
2006-12-26
2006-12-26
Romeo, David S (Department: 1647)
Chemistry: natural resins or derivatives; peptides or proteins;
Proteins, i.e., more than 100 amino acid residues
Blood proteins or globulins, e.g., proteoglycans, platelet...
C530S387300, C530S388100, C530S388150
Reexamination Certificate
active
07153939
ABSTRACT:
The present invention is directed to novel polypeptides and to nucleic acid molecules encoding those polypeptides. Also provided herein are vectors and host cells comprising those nucleic acid sequences, chimeric polypeptide molecules comprising the polypeptides of the present invention fused to heterologous polypeptide sequences, antibodies which bind to the polypeptides of the present invention and to methods for producing the polypeptides of the present invention.
REFERENCES:
patent: 5536637 (1996-07-01), Jacobs
patent: 6287820 (2001-09-01), Umansky et al.
patent: WO1999/028462 (1999-06-01), None
Wu & Moses (Jun. 5, 2003) “BNF-1, a novel gene encoding a putative extracellular matrix protein, is overexpressed in tumor tissues.” Gene 311:105-10.
Merriam-Webster's Medical Dictionary (2002) downloaded from the internet Jan. 31, 2005.
American Heritage Dictionary of the English Language (2002) downloaded from internet on Jan. 31, 2005.
Dahiya & Deng (1998) “Molecular prognostic markers in breast cancer.” Breast Cancer Res Treat. 52(1-3): 185-200.
Krajewski et al. (Mar. 1999) “Prognostic significance of apoptosis regulators in breast cancer.” Endocr Relat Cancer 6(1): 29-40.
Giaccone (May 1996) “Oncogenes and antioncogenes in lung tumorigenesis.” Chest 109(5 Suppl): 130S-134S.
Gryfe et al. (Sep.-Oct. 1997) “Molecular biology of colorectal cancer.” Curr Probl Cancer 21(5): 233-300.
Sen (Jan. 2000) “Aneuploidy and cancer.” Curr Opin Oncol. 12(1): 82-88.
Salier et al., Biochemical Journal, (1996) 315:1-9.
Klein et al. Selection for Genes Encoding Secreted Proteins and Receptors.Proc. Natl. Acad. Sci., 93:7108-7113 (1996).
Database Search, DNA Sequence Alignments [BLASTN 2.2.1 [Jul. 12, 2001], NCBI].
Database Search, Protein Sequence Alignments [BLASTP 2.2.1 [Jul. 12, 2001], NCBI].
GenBank Accession No.: P—AAS46101; WO2001/068848-A2; Pub Date: Sep. 20, 2001; K.P. Baker, et al.
GenBank Accession No.: P—AAA37113; WO2000/012708-A2; Pub Date Mar. 9, 2000; K.P. Baker, et al.
GenBank Accession No.: AX376286; WO2001/068848-A2; Pub Date: Sep. 20, 2001; K.P. Baker, et al.
GenBank Accession No.: BC012126; “Generation and Initial Analysis of More than 15,000 Full-Length Human and Mouse cDNA Sequences”, Proc. Natl. Acad. Sci. U.S.A, 99(26), pp. 16899-16903, 2002 R.L. Strausberg, et al.
GenBank Accession No.: AP000694; Direct Submission; Submitted: Nov. 10, 1999; Nobuyoshi Shimizu, Keio University, School of Medicine, Molecular Biology; K. Shibuya, et al.
GenBank Accession No.: AP000695; Direct Submission; Submitted: Nov. 10, 1999; Nobuyoshi Shimizu, Keio University, School of Medicine, Molecular Biology; K. Shibuya, et al.
GenBank Accession No.: AP001726; “The DNA Sequence of Human Chromosome 21” Nature, 405(6784), pp. 311-319, 2000; M. Hattori, et al.
GenBank Accession No.: AF314090; “Mutations in the Gene Encoding Tight Junction Claudin-14 cause Autosomal Recessice Deafness DFNB29” Cell, 104(1), pp. 165-172, 2001; E.R. Wilcox, et al.
GenBank Accession No.: XM—009753; Direct Submission; Submitted: Feb. 6, 2002; NCBI Annotation Project.
GenBank Accession No.: HSAC000005; Direct Submission; Submitted: Sep. 23, 1996; Stanford Human Genome Center; Quackenbush, et al.
GenBank Accession No.: AC024074; Direct Submission; Feb. 23, 2000; DOE Joint Genome Institute.
Dayhoff Accession No.: P—AAU29200; WO2001/068848-A2; Pub Date: Sep. 20, 2001; K.P. Baker, et al.
Dayhoff Accession No.: P—AAY99431; WO2000/012708-A2; Pub Date Mar. 9, 2000; K.P. Baker, et al.
Dayhoff Accession No.: NP—036232; “Tight Junctions of the Blood-Brain Barrier”; Cell. Mol. Neurobiol., 20(1), pp. 57-76, 2000; U. Kniesel, et al.
Dayhoff Accession No.: CLDE—HUMAN; Direct Submission; Submitted: Jan. 21, 1999; T.J. Keen,et al.
Dayhoff Accession No.: P—AAM78559; WO2001/057190-A2; Aug. 9, 2001; YT Tang, et al.
Dayhoff Accession No.: P—AAM79543; WO2001/057190-A2; Aug. 9, 2001; YT Tang, et al.
Wells, J.A., “Additivity of Mutational Effects in Proteins”, Biochemistry, vol. 29, No. 37, pp. 8509-8517, (1990).
J. Thomas Ngo, et al., “Computational Complexity, Protein Structure Prediction and the Levinthal Paradox”, The Protein Folding Problem and Tertiary Structure Prediction, pp. 433-506, Birkhauser Boston 1994.
Peer Bork, “Powers and Pitfalls in Sequence Analysis: The 70% Hurdle”, Genome Research, vol. 10, pp. 398-400, (2000).
Skolnick, et al., “From Genes to Protein Structure and Function: Novel Applications of Computational Approaches in the Genomic Era” Trends in Biotechnology, vol. 18, pp. 34-39 (2000).
Doerks, et al., “Protein Annotation: Dectective Work for Function Prediction”, Trends in Genetics, vol. 14, No. 6., pp. 248-250, (1998).
Temple F. Smith, et al., “The Challenges of Genome Sequence Annotation or ‘The Devil is in the Details’”, Nature Biotechnology, vol. 15, pp. 1222-1223, (Nov. 1997).
Brenner, S.E., “Errors in Genome Function”, Trends in Genetics, vol. 15, No. 4, pp. 132-133, (1999).
Bork, et al., “Go Hunting in Sequence Database but Watch Out for the Traps”, Trends in Genetics, vol. 12, No. 10, pp. 425-427, (1996).
“Nucleic Acid Hybridization—General Aspects”, pp. 33-37, http://www.roche-applied-science.com/PROD—INF/MANUALS/InSitu/pdf/ISH—33-37.pdf, Roche Website, retrieved by examiner May 12, 2004.
NIH Division of Intramural Research, “Nucleic Acid Hybridization”, NIH Website, retrieved by examiner May 12, 2004.
Goddard Audrey
Godowski Paul J.
Gurney Austin L.
Wood William I.
Barnes Elizabeth M.
Dreger Ginger R.
Gamett Daniel C
Genentech Inc.
Kresnak Mark T.
LandOfFree
PRO354 antibodies does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with PRO354 antibodies, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and PRO354 antibodies will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-3655474